JOHN SCHALL

H.R. 1362 & S. 425, "The National Neurological Diseases Surveillance System Act," all sections; " all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010; creation of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health; Fiscal Year 2012 funding for the NIH Institute on Aging; Senate resolution designating April as Parkinsons Awareness Month.

H.R. 1362 & S. 425, "The National Neurological Diseases Surveillance System Act," all sections; " all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010; creation of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health; Fiscal Year 2012 funding for the NIH Institute on Aging; Senate resolution designating April as Parkinsons Awareness Month.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the NIH, Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and a new review divison for Biochemical and Genetic Diseases within the Center for Drug Evaluation Research, Office of New Drugs at FDA; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; "Energy and Water Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; "Interior, Environment, and Related Agencies Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; H.R 4808, "Stem Cell Research Enhancement Act of 2009," all sections; and legislation relating to the extension of the Medicare Part B therapy cap exceptions process.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the NIH, Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and a new review divison for Biochemical and Genetic Diseases within the Center for Drug Evaluation Research, Office of New Drugs at FDA; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; "Energy and Water Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; "Interior, Environment, and Related Agencies Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; H.R 4808, "Stem Cell Research Enhancement Act of 2009," all sections; and legislation relating to the extension of the Medicare Part B therapy cap exceptions process.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the NIH, Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and a new review divison for Biochemical and Genetic Diseases within the Center for Drug Evaluation Research, Office of New Drugs at FDA; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; "Energy and Water Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; "Interior, Environment, and Related Agencies Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; H.R 4808, "Stem Cell Research Enhancement Act of 2009," all sections; and legislation relating to the extension of the Medicare Part B therapy cap exceptions process.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

"Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," regarding the Therapeutic Discovery Project Tax Credit, section relating to expanding access to primary care services and general surgery services, and section relating to the Cures Accerleration Network; H.R. 3962, "Affordable Health Care for America Act," regarding the Therapeutic Discovery Project Tax Credit; H.R. 1362/S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; Fiscal Year 2011 National Institutes of Health funding.

"Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," regarding the Therapeutic Discovery Project Tax Credit, section relating to expanding access to primary care services and general surgery services, and section relating to the Cures Accerleration Network; H.R. 3962, "Affordable Health Care for America Act," regarding the Therapeutic Discovery Project Tax Credit; H.R. 1362/S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; Fiscal Year 2011 National Institutes of Health funding.

"Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," regarding the Therapeutic Discovery Project Tax Credit, section relating to expanding access to primary care services and general surgery services, and section relating to the Cures Accerleration Network; H.R. 3962, "Affordable Health Care for America Act," regarding the Therapeutic Discovery Project Tax Credit; H.R. 1362/S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; Fiscal Year 2011 National Institutes of Health funding.

"Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," regarding the Therapeutic Discovery Project Tax Credit, section relating to expanding access to primary care services and general surgery services, and section relating to the Cures Accerleration Network; H.R. 3962, "Affordable Health Care for America Act," regarding the Therapeutic Discovery Project Tax Credit; H.R. 1362/S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; Fiscal Year 2011 National Institutes of Health funding.